Efficacy and safety of paliperidone palmitate 3-month formulation in Latin American patients with schizophrenia: A subgroup analysis of data from two large phase 3 randomized, double-blind studies-Reference-Cited by-同舟云学术

Efficacy and safety of paliperidone palmitate 3-month formulation in Latin American patients with schizophrenia: A subgroup analysis of data from two large phase 3 randomized, double-blind studies

Published:2019-12 Issue:6 Volume:41 Page:499-510
ISSN:1809-452X
Container-title:Brazilian Journal of Psychiatry
language:
Short-container-title:Braz. J. Psychiatry

Author:

Savitz Adam J.¹^ORCID,Xu Haiyan¹,Gopal Srihari¹,Nuamah Isaac¹,Mathews Maju¹,Soares Bernardo²

Affiliation:

1. Janssen Research & Development, LLC, USA

2. Janssen-Cilag UK, UK

Publisher

FapUNIFESP (SciELO)

Subject

Psychiatry and Mental health

Link

http://www.scielo.br/pdf/rbp/v41n6/1516-4446-rbp-1516444620180153.pdf

Reference35 articles.

1. Relapse in schizophrenia: costs, clinical outcomes and quality of life;Almond S;Br J Psychiatry,2004

2. The evidence for illness progression after relapse in schizophrenia;Emsley R;Schizophr Res,2013

3. Factors associated with relapse in schizophrenia despite adherence to long-acting injectable antipsychotic therapy;Alphs L;Int Clin Psychopharmacol,2016

4. The role of long-acting injectable antipsychotics in schizophrenia: a critical appraisal;Brissos S;Ther Adv Psychopharmacol,2014

5. Long-acting injectable antipsychotics in the treatment of schizophrenia: their role in relapse prevention;Agid O;Expert Opin Pharmacother,2010

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Model-Informed Clinical Development of Once-Every-6-Month Injection of Paliperidone Palmitate in Patients with Schizophrenia: A Pharmacometric Bridging Approach (Part I);European Journal of Drug Metabolism and Pharmacokinetics;2024-05-15

2. Cumulative Clinical Experience of the Use of Paliperidone Palmitate 3-Monthly Long-Acting Injection in the Treatment of Schizophrenia: A Critical Appraisal;Drug, Healthcare and Patient Safety;2023-09

3. Long-Acting Injectable Antipsychotic Treatment for Schizophrenia in Asian Population: A Scoping Review;Neuropsychiatric Disease and Treatment;2023-09

4. Paliperidone 3-Month Injection for Treatment of Schizophrenia: A Narrative Review;Frontiers in Psychiatry;2021-09-21

5. Paliperidone to Treat Psychotic Disorders;Neurology International;2021-07-28